Transforming heart disease detection with a new era of laboratory biomarkers
Leading experts reveal how laboratory biomarkers are transforming emergency and long-term cardiac care around the world
Leading experts reveal how laboratory biomarkers are transforming emergency and long-term cardiac care around the world
Simoa HD-X receives MFDS Class I IVD Import Clearance, enabling the first clinical introduction of Simoa technology in Korea
The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
The new PCR test aids in the diagnosis of infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis
Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds
University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025
The point-of-care test detects and differentiates between three types of Bordetella infection that can cause similar cough symptoms, ensuring patients receive the right diagnosis at the earliest opportunity
Test helps to identify patients at high risk who need intervention or closer monitoring
Stanford Cancer Center South Bay streamlines chemistry test delivery with CLSI AUTO15, boosting lab efficiency and patient care
Part two of the Quality Data, Informed Action webinar series explores how informatics and essential quality indicators can enhance patient safety
Our one day social media takeover on Linkedin
Dr. Manu De Rycker, a Principal Investigator at the University of Dundee, has been named as the newest winner of the WH Pierce Global Impact in Microbiology Prize
Take the survey and submit a guest editorial
Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with non-small cell lung cancer eligible for HER2-targeted therapy
Developed by a physician-led team, the panel arrives pre-plated in a 96-well format and features a modular, breakaway design to reduce waste and streamline lab workflows
New generation of allergen tests to support faster, more accurate diagnosis worldwide
Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success
A study from Karl Landsteiner University of Health Sciences demonstrates HIFU effectively controls prostate cancer and maintains patients’ quality of life.
First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support fast, confident diagnoses
Findings from the study reveal how a repair system inside some bacteria plays a pivotal role in helping them survive commonly-used antibiotics
Guest editorial features key takeaways from Balancing the Future Podcast, episode 9, by METTLER TOLEDO
Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction